Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme.

Burton, Chase; Das, Arabinda; McDonald, Daniel; Vandergrift, William A; Patel, Sunil J; Cachia, David; Bartee, Eric

Burton, Chase; Das, Arabinda; McDonald, Daniel; Vandergrift, William A; Patel, Sunil J; Cachia, David; Bartee, Eric.

Afiliação

Burton C; Department of Microbiology and Immunology, Medical University of South Carolina, SC, USA, bartee@musc.edu.
Das A; Department of Neurosurgery, Medical University of South Carolina, SC, USA.
McDonald D; Department of Radiation Oncology, Medical University of South Carolina, SC, USA.
Vandergrift WA; Department of Neurosurgery, Medical University of South Carolina, SC, USA.
Patel SJ; Department of Neurosurgery, Medical University of South Carolina, SC, USA.
Cachia D; Department of Neurosurgery, Medical University of South Carolina, SC, USA.
Bartee E; Department of Microbiology and Immunology, Medical University of South Carolina, SC, USA, bartee@musc.edu.

Oncolytic Virother ; 7: 107-116, 2018.

Article em En | MEDLINE | ID: mdl-30538967

Palavras-chave

glioblastoma multiforme; myxoma virus; oncolytic virotherapy; standard of care

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncolytic Virother Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google